American College of Mohs Surgery Meeting

Access to Mohs Surgeon a Barrier to Referral
May 16, 2022

A survey asked dermatologists whether they had personal treated head and neck melanoma with excision, and if and when they referred patients with melanoma on the head and neck to a Mohs surgeon.

Sunscreen Education Needed for All Ages
May 16, 2022

Data from one study showed younger women more likely to use sunscreen than older adults.

Multiple Myeloma May Increase Incidence of Melanoma
May 16, 2022

A poster presented at the 2022 American College of Mohs Surgery Annual Meeting not only suggested a link between multiple myeloma and a heightened rate of melanoma, but also demonstrated potential for higher overall mortality rates.

Staging Accuracy for Squamous Cell Carcinoma
May 16, 2022

At the ACMS meeting, Chrysalyne D. Schmults, MD, MScE, highlighted molecular diagnostics for squamous cell carcinoma.

Chart the Changes in NMSC Prevalence and Procedural Treatments
May 15, 2022

Overall, non-melanoma skin cancer (NMSC) visits (all pooled specialties/areas) have been plateauing. However , metropolitan but not rural areas saw an increase in visits where NMSC was the chief complaint. However, the percentage of NMSC in rural areas that is managed by dermatologists and dermatologic surgeons is also on the rise, according to a presentation given at the 2022 American College of Mohs Surgery Annual Meeting.

Topical Tranexamic Acid Shows Efficacy for Postoperative Bleeding Reduction
May 15, 2022

Topical tranexamic acid is an effective wound care adjunct in reducing rates of postoperative bleeding of granulating defects in Mohs micrographic surgical settings.

Periosteal Flap Safety, Effectiveness, and Aesthetic Quality in Posterior Lamella Reconstruction
May 15, 2022

Single-stage periosteal flap technique to treat full-thickness eyelid defects is safe, effective, and aesthetically acceptable, according to a study presented at the 2022 American College of Mohs Surgery Annual Meeting on May 12, 2022.

Hope for the Future: Innovative Physicians Changing the Way Health Care Delivered
May 15, 2022

Marty Makary, MD, MPH, predicts systemwide change in the world of health care.

Carefully Consider Post-Op Bleeding Risk when Treating Patients with Chronic Lymphocytic Leukemia
May 14, 2022

At the current ACMS meeting, Kelsey E. Hirotsu, MD, discussed the bleeding complications seen in patients on ibrutinib for CLL.

Examining These Patient Variables May Help Predict Aggressive Basal Cell Carcinomas
May 14, 2022

A study presented at the current ACMS meeting highlights variables that could predict BCC, including: gender, immune status, and more.